These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7385132)

  • 41. [Results of ophthalmologic surveillance of 54 patients during prolonged administration of antimalarials].
    David-Chaussé J; Bessière E; Vérin P; Magendie P
    J Med Bord; 1967 Feb; 144(2):237-52. PubMed ID: 5604762
    [No Abstract]   [Full Text] [Related]  

  • 42. [Chloroquine-induced atrioventricular block].
    Egersgård JE
    Ugeskr Laeger; 1987 Apr; 149(16):1063-4. PubMed ID: 3576825
    [No Abstract]   [Full Text] [Related]  

  • 43. Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity.
    Aylward JM
    J Am Optom Assoc; 1993 Nov; 64(11):787-97. PubMed ID: 8120333
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sensitivity to UV light during treatment with chloroquine in rheumatoid arthritis.
    Seideman P; Ros AM
    Scand J Rheumatol; 1992; 21(5):245-7. PubMed ID: 1439633
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Neuromyopathy caused by chloroquine].
    Ned Tijdschr Geneeskd; 1972 Aug; 116(33):1474. PubMed ID: 5069836
    [No Abstract]   [Full Text] [Related]  

  • 46. [Results of cortisone withdrawal in 58 cases of rheumatoid polyarthritis].
    David-Chaussé J; Laporte G
    Rev Rhum Mal Osteoartic; 1968 Sep; 35(9):429-42. PubMed ID: 4301152
    [No Abstract]   [Full Text] [Related]  

  • 47. An ophthalmological view on the efficacy and safety of chloroquine versus hydroxychloroquine.
    Easterbrook M
    J Rheumatol; 1999 Sep; 26(9):1866-8. PubMed ID: 10493662
    [No Abstract]   [Full Text] [Related]  

  • 48. [Macular lesions due to synthetic antimalarials].
    Hache JC; Turut P; Dufour D
    Bull Soc Ophtalmol Fr; 1970 Dec; 70(12):1254-60. PubMed ID: 5526400
    [No Abstract]   [Full Text] [Related]  

  • 49. [Oculo-neuro-myopathic syndrome due to chloroquine intoxication].
    Berato J; Commandre F; Albatro J; Gilly R
    Rhumatologie; 1969 Apr; 21(4):123-5. PubMed ID: 5402740
    [No Abstract]   [Full Text] [Related]  

  • 50. Ophthaproblem. Chloroquine or hydroxychloroquine retinopathy.
    Liu W; Sharma S
    Can Fam Physician; 2005 May; 51(5):671, 679-80. PubMed ID: 15934269
    [No Abstract]   [Full Text] [Related]  

  • 51. A randomized, double-blind, multicenter, controlled clinical trial of cyclosporine plus chloroquine vs. cyclosporine plus placebo in early-onset rheumatoid arthritis.
    Miranda JM; Alvarez-Nemegyei J; Saavedra MA; Terán L; Galván-Villegas F; García-Figueroa J; Jara LJ; Barile L;
    Arch Med Res; 2004; 35(1):36-42. PubMed ID: 15036798
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is chloroquine obsolete in treatment of rheumatic disease?
    Marks JS; Power BJ
    Lancet; 1979 Feb; 1(8112):371-3. PubMed ID: 85016
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Complete heart block as a rare complication of treatment with chloroquine.
    Reuss-Borst M; Berner B; Wulf G; Müller GA
    J Rheumatol; 1999 Jun; 26(6):1394-5. PubMed ID: 10381062
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antimalarials as antirheumatic agents and the risk of ocular toxicity.
    Zvaifler NJ
    GP; 1966 Nov; 34(5):128-32. PubMed ID: 5917009
    [No Abstract]   [Full Text] [Related]  

  • 55. [The immunopathogenesis of chronic rheumatoid polyarhtritis and new ways of its treatment].
    Seidel K
    Z Gesamte Inn Med; 1968 Sep; 23(18):545-50. PubMed ID: 5706731
    [No Abstract]   [Full Text] [Related]  

  • 56. [Reactivation of hepatitis B following withdrawal of chloroquine].
    Helbling B; Reichen J
    Schweiz Med Wochenschr; 1994 May; 124(18):759-62. PubMed ID: 8202673
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Chloroquine-induced myopathy and neuropathy: progressive tetraparesis with areflexia that simulates a polyradiculoneuropathy. Two case reports].
    Becerra-Cuñat JL; Coll-Cantí J; Gelpí-Mantius E; Ferrer-Avellí X; Lozano-Sánchez M; Millán-Torné M; Ojanguren I; Ariza A; Olivé A
    Rev Neurol; 2003 Mar 16-31; 36(6):523-6. PubMed ID: 12652413
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Eye diseases induced by ethambutol].
    Motegi T
    Ganka; 1969 Feb; 11(2):86-93. PubMed ID: 5814354
    [No Abstract]   [Full Text] [Related]  

  • 59. Chloroquine: a review.
    Popert AJ
    Rheumatol Rehabil; 1976 Aug; 15(3):235-8. PubMed ID: 968356
    [No Abstract]   [Full Text] [Related]  

  • 60. ERG and EOG potentials after 6 years resochin treatment.
    Svĕrák J; Erbenová Z; Peregrin J; Salavec M
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1971; 14(2):209-13. PubMed ID: 5289898
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.